This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The goal of this study is to define the natural history of b-cell function in adolescents with T2DM. The first phase insulin response to intravenous glucose and the insulin response to intravenous arginine will be performed at diagnosis, 6 months and annually for 4 years in adolescents with T2DM, race and gender-matched adults with T2DM and age, race, gender and weight-matched adolescent controls. We predict that first phase insulin release in adolescents with T2DM will be severely compromised at diagnosis, undergo a phase of recovery with the institution of treatment, and then progress to a state of greater -cell failure despite anti-diabetic therapies.
Showing the most recent 10 out of 502 publications